Elsevier

Biochemical Pharmacology

Volume 49, Issue 5, 1 March 1995, Pages 717-726
Biochemical Pharmacology

Research paper
Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis

https://doi.org/10.1016/0006-2952(94)00493-6Get rights and content

Abstract

Investigations with chemical inhibitors and with inhibitory antibodies specific for cytochrome P4501A-catalyzed ethoxyresorufin (ethoxyphenoxazone) O-deethylation and 2-acetylaminofluorene (N-2-fluorenylacetamide) ring hydroxylation indicated that cytochrome(s) P450 of the 1A subfamily was functionally expressed in human embryonic hepatic tissues at very early stages (days 50–60) of gestation. Lack of detectable capacity of hepatic microsomal enzymes to catalyze either N-hydroxylation of 2-acetylaminofluorene or O-demethylation of methoxyresorufin indicated that functional cytochrome P4501A2 is expressed minimally or negligibly in human embryonic hepatic tissues. By contrast, profound inhibition of the: ring hydroxylation of 2-acetylaminofluorene and of the O-deethylation of ethoxyresorufln by 7,8-benzoflavone as well as by anti-cytochrome P4501A1 antibodies indicated the presence of significant levels of functional cytochrome P4501A1 in hepatic microsomes of human embryos. Using the reverse transcriptase-linked polymerase chain reaction with specific oligonucleotide primers, we also detected significant expression of cytochrome P4501A1 mRNA in human embryonic livers. Polymerase chain reaction amplification, cloning and sequencing of the corresponding cDNA provided evidence that the cytochrome P4501A1 mRNA expressed in human embryonic tissues was identical to that expressed in adult human tissues. The results of the study have important implications in terms of the embryotoxic effects of chemicals that are known to be substrates, inhibitors or inducers of cytochrome P4501A1 and to which pregnant women are exposed.

References (34)

  • PL Ey et al.

    Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose

    Immunochemistry

    (1978)
  • HL Yang et al.

    Organogenesis-stage P450 isoforms: Utilization of PCR for detection of CYP1A1 mRNA in rat conceptal tissues

    Biochem Biophys Res Commun

    (1991)
  • P Chomczynski et al.

    Single step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction

    Anal Biochem

    (1987)
  • IB Tsyrlov et al.

    Enzymekinetic and immunochemical characteristics of mouse cDNA expressed, microsomal, and purified CYP1A1 and CYP1A2

    Arch Biochem Biophys

    (1993)
  • T Kamataki et al.

    Molecular toxicology on cytochrome P450 in human fetal livers

    J Toxicol Sci

    (1991)
  • JE Hulla et al.

    Occurrence and inducibility of cytochrome P450IIIA in maternal and fetal rats during prenatal development

    Biochemistry

    (1989)
  • JE Hulla et al.

    Developmental aspects of P450IIIA: Prenatal activity and inducibility

    Drug Metab Rev

    (1989)
  • Cited by (50)

    • Application of reaction phenotyping to address pharmacokinetic variability in patient populations

      2023, Overcoming Obstacles in Drug Discovery and Development: Surmounting the Insurmountable-Case Studies for Critical Thinking
    • Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics

      2022, Advances in Pharmacology
      Citation Excerpt :

      In adults, CYP1A1 exists largely extrahepatically, such as in the lung and placenta, and is known to be induced by cigarette smoking and/or other inducers mediated through an aryl hydrocarbon receptor (Zevin & Benowitz, 1999). However, the mRNA of CYP1A1 has been identified in fetal livers aged as early as 45 days of gestation and its expression was higher in older gestational ages (Omiecinski, Redlich, & Costa, 1990; Yang, Namkung, & Juchau, 1995). Interestingly, its immunoreactive expression in fetal livers showed no apparent zonal distribution (Murray et al., 1992).

    • Pharmacology of Pediatric Anesthesia

      2006, Smith's Anesthesia for Infants and Children
    • Ontogeny of drug metabolizing enzymes in the neonate

      2005, Seminars in Fetal and Neonatal Medicine
    View all citing articles on Scopus
    View full text